NCT03650621

Brief Summary

The purpose is to investigate whether non-invasive acupuncture - NIA (i.e. acupuncture without needles) will help reduce pain for babies in the Neonatal Intensive Care Unit (NICU) during their routine weekly eye-exam for Retinopathy of prematurity. Retinopathy of prematurity (ROP) is an eye disease most commonly affecting premature babies born weighing less than 1250 grams. Retinopathy of prematurity occurs because these premature babies require oxygen because of their immature lungs. The oxygen then stimulates the growth of blood vessels in the retina, causing the retina to be detached from the eye, which causes vision impairment. To examine if the vessels grow at the back of the eye, an eye-doctor visits bi-weekly once the baby is 32 weeks corrected age to assess if the blood vessels change. If there is a lot of growth, the eye-doctor would use a laser to treat the eye to prevent further growth. During the bi-weekly eye-exam, the premature infant receives sucrose (a type of sugar) for pain management. The investigator will assess pain a premature babies experience during this exam and found that there are extremely high scores of pain despite sucrose and the investigator believe this pain and stress caused by these procedures could be reduced by adding: Magnetic Acupuncture Also, untreated pain causes stress (lower oxygen levels, higher heart rates), discomfort and poorer long term outcomes. Finding the best treatment and prevention for the pain caused by procedures in the NICU is therefore extremely important for any baby.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 24, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

September 19, 2024

Status Verified

July 1, 2020

Enrollment Period

1.1 years

First QC Date

June 26, 2018

Last Update Submit

September 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in Premature Infant Pain Profile (PIPP) scores

    Mean pain scores on the Premature Infant Pain Profile (PIPP) scores

    Comparison of baseline (= 1 hour before eye-exam) and after eye-exam (1 hour after)

Secondary Outcomes (3)

  • Heart rate changes

    changes in heart rate in beats per minute 1 hour before and 1 hour after eye-exam

  • Changes in oxygen saturation

    changes in oxygen saturation in % 1 hour before and 1 hour after eye-exam

  • changes in cerebral oxygenation

    changes in cerebral oxygenation % 1 hour before and 1 hour after eye-exam

Study Arms (2)

Intervention - Magnetic acupuncture

EXPERIMENTAL

Infants randomized to the intervention arm will have 5 magnetic stickers placed on both ears approximately 1 hour before the eye-exam and will stay in place for approximately 1 hour after the eye-exam. Total duration of study 2.5-3 hours

Device: Magnetic acupuncture

Control - Placebo control

PLACEBO COMPARATOR

In this arm the infants will have 5 stickers (magnets removed) placed on their ear approximately 1 hour before the eye-exam and will stay in place for approximately 1 hour after the eye-exam. Total duration of study 2.5-3 hours

Device: stickers (magnets removed)

Interventions

5 magnetic acupuncture stickers will be placed on the infants ear

Intervention - Magnetic acupuncture

in this group 5 stickers (magnets removed) will be placed on the infants ear

Control - Placebo control

Eligibility Criteria

Age29 Weeks - 36 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • Chronic pain stimuli (e.g. infants who have had recent surgery)
  • Neurological problems that could impair pain perception (e.g. diagnosis of intraventricular hemorrhages Grade III or greater)
  • Cardiorespiratory problems that could impair oxygenation (e.g. any infant who is intubated and requiring mechanical ventilation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Sydney

Sydney, New South Wales, Australia

Location

Royal Alexandra Hospital

Edmonton, Alberta, T5H 3V9, Canada

Location

University of Malaya Medical Centre

Kuala Lumpur, Malaysia

Location

Related Publications (1)

  • Gan KML, Oei JL, Quah-Smith I, Kamar AA, Lordudass AAD, Liem KD, Lindrea KB, Daly M, Gaunker N, Mangat AK, Yaskina M, Schmolzer GM. Magnetic Non-invasive Auricular Acupuncture During Eye-Exam for Retinopathy of Prematurity in Preterm Infants: A Multicentre Randomized Controlled Trial. Front Pediatr. 2020 Dec 23;8:615008. doi: 10.3389/fped.2020.615008. eCollection 2020.

MeSH Terms

Conditions

Retinopathy of PrematurityPainPremature Birth

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Georg Schmolzer, MD, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
patients are preterm infants and therefore mask, health care providers will be masked as well as outcome assessors.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: this is a 2-arm parallel design randomized controlled trial with 3 sites recruiting infants
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2018

First Posted

August 29, 2018

Study Start

August 24, 2018

Primary Completion

September 30, 2019

Study Completion

April 30, 2020

Last Updated

September 19, 2024

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
once study has been completed
Access Criteria
email to PI

Locations